Pain Management

Extended-release naltrexone and sublingual buprenorphine-naloxone are pharmacologically distinct interventions to prevent opioid relapse.

Previous evidence has suggested that vitamin D may play a role in chronic non-specific widespread pain, which is associated with disability and reduced quality of life. A new study assessed this association...

Previous evidence has suggested that vitamin D may play a role in chronic non-specific widespread pain, which is associated with disability and reduced quality of life. A new study assessed this association...

The President’s Commission on Combating Drug Addiction and Opioid Crisis has issued 56 recommendations for addressing the opioid crisis.

In 2015, 33,091 deaths involved the use of opioids. Last night, the president made an official declaration on the opioid crisis in the United States.

Recently, researchers investigated whether multimodal pain management strategies have impacted opioid usage among patients undergoing total joint arthroplasty over the last 10 years.

Recently, researchers investigated whether multimodal pain management strategies have impacted opioid usage among patients undergoing total joint arthroplasty over the last 10 years.

Chronic opioid use has led to increased tolerance to commonly used sedatives. In a new study, researchers tested the safety and efficacy of an adjunctive sedative for chronic opioid users who were scheduled...

After results from a clinical trial demonstrated its safety and efficacy, the US Food and Drug Administration recently approved the first and only extended-release intra-articular injection for patients...

In a recent study, researchers sought to determine whether knee or hip pain is more prevalent with contralateral or ipsilateral foot pain.